Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1038/s41587-021-00878-8 http://scihub22266oqcxt.onion/10.1038/s41587-021-00878-8 33767397!8355051!33767397     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Nat+Biotechnol 2021 ; 39 (8): 928-935 Nephropedia Template TP {{tp|p=33767397|t=2021. Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection |pdf=|usr=}}{{33767397}} gab.com Text Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection JO: Nat Biotechnol http://www.kidney.de/pget.php?&tw=1&pmid=33767397 #FOAvip Current serology tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies mainly take the form of enzyme-linked immunosorbent assays, chemiluminescent microparticle immunoassays or lateral flow assays, which are either laborious, expensive or lacking sufficient sensitivity and scalability. Here we present the development and validation of a rapid, low-cost, solution-based assay to detect antibodies in serum, plasma, whole blood and to a lesser extent saliva, using rationally designed split luciferase antibody biosensors. This new assay, which generates quantitative results in 30 min, substantially reduces the complexity and improves the scalability of coronavirus disease 2019 (COVID-19) antibody tests. This assay is well-suited for point-of-care, broad population testing, and applications in low-resource settings, for monitoring host humoral responses to vaccination or viral infection. Twit Text FOAVip Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection ????Nat Biotechnol http://www.kidney.de/pget.php?&tw=1&pmid=33767397 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33767397 #FOAvip English Wikipedia <ref>{{Cite pmid|33767397}}</ref> Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection #MMPMID33767397 Elledge SK; Zhou XX; Byrnes JR; Martinko AJ; Lui I; Pance K; Lim SA; Glasgow JE; Glasgow AA; Turcios K; Iyer NS; Torres L; Peluso MJ; Henrich TJ; Wang TT; Tato CM; Leung KK; Greenhouse B; Wells JA Nat Biotechnol 2021[Aug]; 39 (8): 928-935 PMID33767397show ga Current serology tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies mainly take the form of enzyme-linked immunosorbent assays, chemiluminescent microparticle immunoassays or lateral flow assays, which are either laborious, expensive or lacking sufficient sensitivity and scalability. Here we present the development and validation of a rapid, low-cost, solution-based assay to detect antibodies in serum, plasma, whole blood and to a lesser extent saliva, using rationally designed split luciferase antibody biosensors. This new assay, which generates quantitative results in 30 min, substantially reduces the complexity and improves the scalability of coronavirus disease 2019 (COVID-19) antibody tests. This assay is well-suited for point-of-care, broad population testing, and applications in low-resource settings, for monitoring host humoral responses to vaccination or viral infection. |*Point-of-Care Systems[MESH] |Antibodies, Viral/*blood[MESH] |Biosensing Techniques/*methods[MESH] |COVID-19 Serological Testing/*methods[MESH] |COVID-19/*diagnosis/virology[MESH] |Humans[MESH] |Luminescence[MESH]Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibo(epmc).pdf DeepDyve Pubget Overpricing